Van de Stadt et al. showed that titers of ACPA levels increased approximately 2–4 years before diagnosis of RA [45] and ACPA levels have been described to have a more pro-inflammatory profile in RA risk [46]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.